100 related articles for article (PubMed ID: 1258658)
1. Potential hypolipidemic agents. XIII. Synthesis and plasma lipid-lowering properties of some acetals derived from 3-pyridylmethanol or nicotinaldehyde.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1976; 13(1):1-8. PubMed ID: 1258658
[No Abstract] [Full Text] [Related]
2. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
3. Potential hypolipidemic agents. XII. Synthesis and plasma lipid-lowering properties of some 3-pyridylmethyl ethers.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(5-6):445-54. PubMed ID: 1217497
[No Abstract] [Full Text] [Related]
4. Potential hypolipidemic agents. XVI. Synthesis and plasma lipid-lowering properties of alpha-substituted ethyl 4-dibenzofuranyloxyacetates and ethyl 4-chlorophenoxyacetates. A comparative study.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1977; 14(2):137-48. PubMed ID: 906831
[No Abstract] [Full Text] [Related]
5. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate.
Bondesson G; Högberg T; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013
[No Abstract] [Full Text] [Related]
6. Potential hypolipidemic agents. XX. Synthesis and lipid-lowering properties of annelated thiophenecarboxylic acids.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):368-81. PubMed ID: 747095
[No Abstract] [Full Text] [Related]
7. [Comparative clinico-pharmacological studies on the lipid lowering effect of EMO 100 and clofibrate].
Leopold G; Simane Z; Stoll KD; Breuer J
Med Welt; 1975 Aug; 6(35):1542-4. PubMed ID: 1177741
[No Abstract] [Full Text] [Related]
8. Potential hypolipidemic agents. XVIII. Synthesis and lipid-lowering properties of 2-(dibenzothiophenoxy)-2-methylpropionates and related compounds.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):337-60. PubMed ID: 747093
[No Abstract] [Full Text] [Related]
9. Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate.
Gronowitz S; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):361-7. PubMed ID: 747094
[No Abstract] [Full Text] [Related]
10. Potential hypolipidemic agents. XI. Synthesis, plasma lipid-lowering properties and bioavailability of some esters of 2-(4-dibenzofuranoloxy)-2-methylpropionic acid.
Bondesson G; Högberg T; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(4):361-74. PubMed ID: 1199735
[No Abstract] [Full Text] [Related]
11. Synthesis and hypolipidemic activity of some new esters of glycerol and 2-O-methyl-glycerol with nicotinic and 5-fluoro-nicotinic acids.
Dall'Asta L; Comini A; Borella F; Berti MA; Coppi G
Boll Chim Farm; 1989 Mar; 128(3):106-10. PubMed ID: 2775523
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of a retard preparation of beta-pyridylcarbinol using a new automated assay method].
Schräpler P; Schulz E; Scholer A
Med Welt; 1977 Nov; 28(46):1900-3. PubMed ID: 593135
[No Abstract] [Full Text] [Related]
13. Potential hypolipidemic agents. XV Synthesis and plasma lipid-lowering properties of derivatives of 2-phenoxy-2-methylpropionic acid.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(5-6):427-38. PubMed ID: 1020658
[No Abstract] [Full Text] [Related]
14. Newer hypolipidemic agents.
Kritchevsky D
Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
[No Abstract] [Full Text] [Related]
15. 2-Substituted-3-pyridinolethers as hypolipidemic and platelet aggregation inhibiting agents.
Desideri N; Manna F; Stein ML; Vairo G; Del Gaudio F; Gentile B; Marmo E
Farmaco Sci; 1985 Sep; 40(9):630-44. PubMed ID: 3841074
[TBL] [Abstract][Full Text] [Related]
16. [Effect on lipidemia in the rat of bis-homoanalogs of adenine nucleosides].
Gaggi R; Giovanninetti G; Cavrini V; Garuti L; Roveri P; Amorosa M; Defaye J
Farmaco Sci; 1980 Jul; 35(7):581-9. PubMed ID: 7450047
[TBL] [Abstract][Full Text] [Related]
17. Pantetheine and pantethine esters with hypolipidemic nicotinic acid derivatives.
Picciòla G; Calvi E; Ravenna F; Gentili P; Manzardo S; Riva M
Arzneimittelforschung; 1985; 35(12):1768-71. PubMed ID: 4096728
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and hypotriglyceridemic effect of various 2-phenylthis-3-pyridinesulfonamides].
Delarge J; Ghys A
Farmaco Sci; 1983 Jan; 38(1):9-14. PubMed ID: 6825834
[No Abstract] [Full Text] [Related]
19. Effects of nicotinic acid, nicotinamide, and pyridylcarbinol in pharmacological dosages on lipid metabolism in humans.
Zöllner N
Int J Vitam Nutr Res Suppl; 1989; 30():114-9. PubMed ID: 2529321
[TBL] [Abstract][Full Text] [Related]
20. [Cholesterol and lipid lowering effects and vascular action of p-chlororphenoxy-alpha-isobutyrate of 3-hydroxymethyl-pyridine-hydrochloric acid (clofinol)].
Marmo E; Caputi AP; Vacca C; Imperatore A; Cataldi S
Clin Ter; 1974 Mar; 68(6):519-67. PubMed ID: 4831379
[No Abstract] [Full Text] [Related]
[Next] [New Search]
